New Zealand markets open in 6 hours 49 minutes

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.4362-0.0054 (-1.22%)
As of 10:10AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
94,272
93,790
61,464
42,794
13,286
-
Selling general and administrative
27,127
33,304
32,552
21,228
6,709
-
Total operating expenses
121,399
126,937
88,855
55,187
18,674
-
Operating income or loss
-121,399
-126,937
-88,855
-55,187
-18,674
-
Interest expense
-
-
-
3
367
346
Total other income/expenses net
7,948
9,265
-6,784
334
-1,038
-
Income before tax
-113,451
-117,672
-95,639
-54,853
-19,955
-
Income from continuing operations
-113,451
-117,672
-95,639
-54,853
-19,955
-
Net income
-113,451
-117,672
-95,639
-54,853
-19,955
-
Net income available to common shareholders
-113,451
-117,672
-95,639
-55,274
-19,955
-
Basic EPS
-3.17
-3.09
-2.53
-1.49
-1.67
-
Diluted EPS
-3.17
-3.09
-2.53
-1.49
-1.67
-
Basic average shares
37,958
38,020
37,733
36,921
11,967
-
Diluted average shares
37,958
38,020
37,733
36,921
11,967
-